Which Medicare codes bring in the most money for a practice? CMS data for 2024 shows that office visit code 99214 alone accounted for $11,425 million in allowed charges in the office setting, or 10.5% of the $108.4 billion allowed there. Code 99213 came second at $5,530 million, or 5.1%.
The two codes together made up 15.6% of the office total. The 12 largest codes made up 31.0%, and the office setting held 6,419 distinct codes.
What the CMS data counts
The Centers for Medicare & Medicaid Services (CMS) publishes the Medicare Physician & Other Practitioners by Geography and Service file each year. The 2024 release was last modified on May 21, 2026. It lists services, beneficiaries and the average Medicare allowed amount for every code, split by place of service.
This article multiplies services by the average allowed amount to get allowed dollars for each code. Allowed dollars include the Medicare payment and the patient's deductible and coinsurance.
Across all settings, the file totals $153.1 billion in allowed charges on 3,554 million services. Office settings account for $108.4 billion of that, or 70.8%. The same office total was $99.6 billion in 2023, so it grew 8.9% in one year. Medicare Advantage claims are not in the file.
The 12 largest codes in the office setting
The table ranks office-setting codes by 2024 allowed dollars. The last column compares each code with the same code in 2023.
| Rank | Code | Description | Services (millions) | Allowed ($ millions) | Share of office total | Average allowed per service | Change in allowed dollars from 2023 |
|---|---|---|---|---|---|---|---|
| 1 | 99214 | Established patient visit, level 4 | 95.44 | $11,425 | 10.5% | $120 | +2.8% |
| 2 | 99213 | Established patient visit, level 3 | 64.78 | $5,530 | 5.1% | $85 | -3.1% |
| 3 | J0178 | Aflibercept injection, 1 mg | 2.71 | $2,227 | 2.1% | $822 | -25.2% |
| 4 | J9271 | Pembrolizumab injection, 1 mg | 38.02 | $2,102 | 1.9% | $55 | +5.2% |
| 5 | J2777 | Faricimab-svoa injection, 0.1 mg | 53.96 | $1,854 | 1.7% | $34 | +48.1% |
| 6 | 99204 | New patient visit, level 4 | 11.40 | $1,828 | 1.7% | $160 | +0.6% |
| 7 | 99215 | Established patient visit, level 5 | 10.33 | $1,752 | 1.6% | $170 | +6.5% |
| 8 | 97110 | Therapeutic exercise, per 15 minutes | 64.20 | $1,463 | 1.3% | $23 | -3.5% |
| 9 | Q4205 | Membrane graft or wrap, per square centimeter | 1.10 | $1,428 | 1.3% | $1,302 | +330.2% |
| 10 | 97530 | Therapeutic activities, per 15 minutes | 44.64 | $1,408 | 1.3% | $32 | +16.7% |
| 11 | J0897 | Denosumab injection, 1 mg | 55.34 | $1,403 | 1.3% | $25 | +9.6% |
| 12 | G0439 | Annual wellness visit, subsequent | 10.02 | $1,183 | 1.1% | $118 | +4.0% |
Source: CMS, Medicare Physician & Other Practitioners by Geography and Service, calendar years 2024 and 2023, office place of service. Allowed dollars are services multiplied by average allowed amount, calculated for this article.
Office visits carry the list
Five of the 12 largest office codes are visits or wellness visits. They are 99214, 99213, 99204, 99215 and G0439. Together they total $21,718 million, or 20.0% of the office total.
All nine standard office visit codes (99202 to 99205 and 99211 to 99215) total $22.3 billion, or 20.6% of the office setting. Level 4 and level 3 established visits dominate that group. Level 4 visits grew 2.8% in allowed dollars from 2023, while level 3 visits fell 3.1%.
The gap in volume is smaller than the gap in dollars. CMS counted 95.44 million level 4 services and 64.78 million level 3 services. The average allowed amount was $120 for level 4 and $85 for level 3, a difference of $35 per visit. Level 5 visits paid $170 on average, but they totaled only 10.33 million services.
New patient visits are small by volume. Code 99204 had 11.40 million services and $1,828 million allowed. Code 99203 had $850 million and 99205 had $500 million.
Drugs, skin substitutes and therapy codes
Four injectable drug codes are in the top 12: J0178, J9271, J2777 and J0897. Their allowed dollars sum to $7,586 million, or 7.0% of the office total. A skin substitute code, Q4205, adds $1,428 million. Drug and supply codes in the group total $9,014 million, or 8.3%.
These codes pay on a per-unit basis, so the average amount tells little about one patient. Aflibercept (J0178) averaged $822 per unit on 2.71 million units. Pembrolizumab (J9271) averaged $55 per unit on 38.02 million units. Allowed dollars for aflibercept fell 25.2% from 2023, while faricimab-svoa (J2777) rose 48.1%.
The largest change on the list belongs to Q4205, a membrane graft code. Its allowed dollars rose 330.2% in one year, to $1,428 million at $1,302 per square centimeter.
Two physical therapy codes, 97110 and 97530, add $2,871 million, or 2.6% of the office total. They pay $23 and $32 per service, so their rank comes from volume: 64.20 million and 44.64 million services.
Reading your own practice against the list
A practice can compare its own mix with these national shares. If level 4 and level 3 visits make up well under 15.6% of Medicare allowed dollars, the practice either has a large procedure or drug line or a different specialty mix. If they make up far more, visit coding and visit volume drive most of the revenue.
The national table gives three fixed points for that check. The average allowed amount for 99214 is $120. For 99213 it is $85. The annual wellness visit G0439 averages $118, with 10.02 million services in 2024.
Specialty matters. The national file mixes primary care, ophthalmology, oncology, orthopedics and therapy practices. A retina group will see J0178 and J2777 at the top of its own list. A primary care group will see 99214, 99213 and G0439.
Sources
- CMS, Medicare Physician & Other Practitioners by Geography and Service, calendar year 2024, modified May 21, 2026
- CMS, Medicare Physician & Other Practitioners by Geography and Service, calendar year 2023 data
Talk to us
Fifteen minutes about your practice and the systems you run.